Prestige Consumer Healthcare Inc. buy BMO Capital Markets
Start price
15.11.23
/
50%
€53.50
Target price
15.11.24
€107.78
Performance (%)
42.99%
End price
16.11.24
€76.50
Summary
This prediction ended on 16.11.24 with a price of €76.50. The BUY prediction by BMO_Capital_Markets for Prestige Consumer Healthcare Inc. saw massive gains of 42.99%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -0.417% | -0.417% | -31.223% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by BMO_Capital_Markets for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target lowered by analysts at BMO Capital Markets from $124.00 to $117.00. They now have an "outperform" rating on the stock.
Ratings data for PBH provided by MarketBeat
In the thread Trading Prestige Consumer Healthcare Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten